Promega signed a license agreement with BrainXell, a Madison-based producer of iPSC-derived human cells such as neurons and glia, the company announced today.

“Reporter-enabled human neural models take expertise that few labs have in-house,” Promega Associate Fellow, Product Discovery & Adoption Kevin Kopish said in a statement. “This license creates valuable access by authorizing BrainXell to build Promega technologies into those models for research teams.”

According to a release, BrainXell is authorized to engineer HaloTag®, NanoLuc® and NanoBiT® technologies into induced pluripotent stem cell (iPSC) lines and iPSC-derived models of the central nervous system.

The two companies will present at the Society of Neuroscience (SfN) Annual Meeting from Nov. 14-18.